Osiris Therapeutics

About:

Osiris Therapeutics is a stem cell company, which focuses on developing and marketing products to treat medical conditions.

Website: http://osiris.com

Top Investors: Mesoblast, SOSV, Arvind Gupta, Friedli Corporate Finance

Description:

Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources.

Total Funding Amount:

$95M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Columbia, Maryland, United States

Founded Date:

1992-12-23

Contact Email:

Osiris(AT)Osiris.com

Founders:

James S. Burns

Number of Employees:

501-1000

Last Funding Date:

2018-07-06

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai